Skip to content

Klebert de Paula Malheiros

2 papers in the library · publishing 2024-2026

Papers

Study of the Biology, Medicinal and Therapeutic Properties of Amanita muscaria (L) Lam. (Basidiomycota: Agaricales: Amanitaceae)

Middle East Research Journal of Medical Sciences January 2, 2026 Marco Vinícios de Oliveira Santana, Carlos Henrique Marchiori, Klebert de Paula Malheiros

The fly agaric mushroom (Amanita muscaria) is a visually distinctive species with a red cap and white spots. Its bioactive compounds—muscimol, ibotenic acid, and muscarine—have psychoactive, neuroactive, and therapeutic properties. Recent research suggests potential roles in neurodegenerative conditions like Parkinson's, Alzheimer's, epilepsy, and depression through interactions with GABAergic and glutamatergic neurotransmission. Laboratory findings indicate possible anti-inflammatory, neuroprotective, hepatoprotective, and antioxidant effects, though toxicity limits clinical use and requires careful dosing and preparation. This review covers the mushroom's biology, distribution, toxicology, medicinal potential, and traditional uses.

The Action on Psilocybin in Neural Plasticity, Brain Reorganization and Cognitive Enhancement

Middle East Research Journal of Biological Sciences September 28, 2024 Carlos Henrique Marchiori, Marco Vinícios de Oliveira Santana, Klebert de Paula Malheiros

Psilocybin and psilocin do not cause addiction or dependence because they do not interact with the dopaminergic reward system. This narrative review examines psilocybin's action on neural plasticity, brain reorganization, and cognitive enhancement. Psilocybin is an indole alkaloid of the hallucinogenic tryptamine group, structurally similar to serotonin. In Brazil, it is authorized by Anvisa through Ordinance 344 of 1998 with special authorization. The review suggests psilocybin may improve conditions such as depression, anxiety, and cognition, and help with withdrawal symptoms from addiction, with increased concentration and improved brain activity.